Billing Codes — Australian Health Schedule Tracker

Showing 851–900 of 6045 Pg 18/121

	Item No.	Description	Category	Schedule Fee	100% Benefit	Status
	18276	PARAVERTEBRAL NERVES, injection of an anaesthetic agent, (multiple levels) Group T7	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18276 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.1993 Gov. Change Flags Fee ≠ Full Description PARAVERTEBRAL NERVES, injection of an anaesthetic agent, (multiple levels) Sign in to watch this code → Get an email alert when this item changes
	18278	Sciatic nerve, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach Group T7	Category 3 — Therapeutic Procedures	$106.05	—	≠ CHANGED
Item Number 18278 Schedule Fee $106.05 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.1993 Gov. Change Flags Fee ≠ Full Description Sciatic nerve, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach Sign in to watch this code → Get an email alert when this item changes
	18280	Sphenopalatine ganglion, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach (Anaes.) Group T7	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18280 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.1993 Gov. Change Flags Fee ≠ Full Description Sphenopalatine ganglion, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18282	Carotid sinus, injection of an anaesthetic agent, as an independent percutaneous procedure (H) Group T7	Category 3 — Therapeutic Procedures	$120.70	—	≠ CHANGED
Item Number 18282 Schedule Fee $120.70 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.1993 Gov. Change Flags Fee ≠ Full Description Carotid sinus, injection of an anaesthetic agent, as an independent percutaneous procedure (H) Sign in to watch this code → Get an email alert when this item changes
	18284	Cervical or thoracic sympathetic chain, injection of an anaesthetic agent (H) (Anaes.) Group T7	Category 3 — Therapeutic Procedures	$176.70	—	≠ CHANGED
Item Number 18284 Schedule Fee $176.70 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.1993 Gov. Change Flags Fee ≠ Full Description Cervical or thoracic sympathetic chain, injection of an anaesthetic agent (H) (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18286	Lumbar or pelvic sympathetic chain, injection of an anaesthetic agent (H) (Anaes.) Group T7	Category 3 — Therapeutic Procedures	$176.70	—	≠ CHANGED
Item Number 18286 Schedule Fee $176.70 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.1993 Gov. Change Flags Fee ≠ Full Description Lumbar or pelvic sympathetic chain, injection of an anaesthetic agent (H) (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18288	Coeliac plexus or splanchnic nerves, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach (H) (Anaes.) Group T7	Category 3 — Therapeutic Procedures	$176.70	—	≠ CHANGED
Item Number 18288 Schedule Fee $176.70 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.1993 Gov. Change Flags Fee ≠ Full Description Coeliac plexus or splanchnic nerves, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach (H) (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18290	Cranial nerve other than trigeminal, destruction by a neurolytic agent under image guidance, other than a service associated with the injection of botulinum toxin (Anaes.) Group T7	Category 3 — Therapeutic Procedures	$298.85	—	≠ CHANGED
Item Number 18290 Schedule Fee $298.85 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.1993 Gov. Change Flags Fee ≠ Full Description Cranial nerve other than trigeminal, destruction by a neurolytic agent under image guidance, other than a service associated with the injection of botulinum toxin (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18292	Nerve branch, destruction by a neurolytic agent under image guidance, other than a service to which another item in this Group applies or a service associated with the injection of botulinum toxin except a service to which item 18354 applies (Anaes.) Group T7	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18292 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.1993 Gov. Change Flags Fee ≠ Full Description Nerve branch, destruction by a neurolytic agent under image guidance, other than a service to which another item in this Group applies or a service associated with the injection of botulinum toxin except a service to which item 18354 applies (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18294	Coeliac plexus or splanchnic nerves, destruction by a neurolytic agent under image guidance (H) (Anaes.) Group T7	Category 3 — Therapeutic Procedures	$210.70	—	≠ CHANGED
Item Number 18294 Schedule Fee $210.70 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.1993 Gov. Change Flags Fee ≠ Full Description Coeliac plexus or splanchnic nerves, destruction by a neurolytic agent under image guidance (H) (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18296	Lumbar or pelvic sympathetic chain, destruction by a neurolytic agent under image guidance (H) (Anaes.) Group T7	Category 3 — Therapeutic Procedures	$180.15	—	≠ CHANGED
Item Number 18296 Schedule Fee $180.15 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.1993 Gov. Change Flags Fee ≠ Full Description Lumbar or pelvic sympathetic chain, destruction by a neurolytic agent under image guidance (H) (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18297	Assistance at the administration of an epidural blood patch (a service to which item 18233 applies) by another medical practitioner Group T7	Category 3 — Therapeutic Procedures	$71.00	—	≠ CHANGED
Item Number 18297 Schedule Fee $71.00 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.2019 Gov. Change Flags Fee ≠ Full Description Assistance at the administration of an epidural blood patch (a service to which item 18233 applies) by another medical practitioner Sign in to watch this code → Get an email alert when this item changes
	18298	CERVICAL OR THORACIC SYMPATHETIC CHAIN, destruction by a neurolytic agent (Anaes.) Group T7	Category 3 — Therapeutic Procedures	$210.70	—	≠ CHANGED
Item Number 18298 Schedule Fee $210.70 Category Category 3 — Therapeutic Procedures Group / Subheading Group T7 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.1993 Gov. Change Flags Fee ≠ Full Description CERVICAL OR THORACIC SYMPATHETIC CHAIN, destruction by a neurolytic agent (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18350	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of hemifacial spasm in a patient who is at least 12 years of age, including all such injections on any one day Group T11	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18350 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.05.2003 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of hemifacial spasm in a patient who is at least 12 years of age, including all such injections on any one day Sign in to watch this code → Get an email alert when this item changes
	18351	Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport), injection of, for the treatment of hemifacial spasm in a patient who is at least 18 years of age, including all such injections on any one day Group T11	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18351 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.2005 Gov. Change Flags Fee ≠ Full Description Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport), injection of, for the treatment of hemifacial spasm in a patient who is at least 18 years of age, including all such injections on any one day Sign in to watch this code → Get an email alert when this item changes
	18353	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of cervical dystonia (spasmodic torticollis), including all such injections on any one day Group T11	Category 3 — Therapeutic Procedures	$298.85	—	≠ CHANGED
Item Number 18353 Schedule Fee $298.85 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: D Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.04.2015 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of cervical dystonia (spasmodic torticollis), including all such injections on any one day Sign in to watch this code → Get an email alert when this item changes
	18354	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of dynamic equinus foot deformity (including equinovarus and equinovalgus) due to spasticity from cerebral palsy, if: (a) the patient is at least 2 years of age; and (b) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each lower limb), including all injections per set (Anaes.) Group T11	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18354 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.05.2003 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of dynamic equinus foot deformity (including equinovarus and equinovalgus) due to spasticity from cerebral palsy, if: (a) the patient is at least 2 years of age; and (b) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each lower limb), including all injections per set (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18355	IncobotulinumtoxinA (Xeomin), injection of, for the treatment of chronic sialorrhea in a patient who is at least 2 years of age, if the condition is due to a neurological or neurodevelopmental disorder, including all such injections on any one day (Anaes.) Group T11	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18355 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.03.2026 Gov. Change Flags Fee ≠ Full Description IncobotulinumtoxinA (Xeomin), injection of, for the treatment of chronic sialorrhea in a patient who is at least 2 years of age, if the condition is due to a neurological or neurodevelopmental disorder, including all such injections on any one day (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18360	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), or Clostridium Botulinum Type A Toxin Haemagglutinin Complex (Dysport), injection of, for the treatment of moderate to severe focal spasticity, if: (a) the patient is at least 18 years of age; and (b) the spasticity is associated with a previously diagnosed neurological disorder; and (c) treatment is provided as: (i) second line therapy when standard treatment for the conditions has failed; or (ii) an adjunct to physical therapy; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each limb), including all injections per set; and (e) the treatment is not provided on the same occasion as a service mentioned in item 18365 Group T11	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18360 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.05.2003 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), or Clostridium Botulinum Type A Toxin Haemagglutinin Complex (Dysport), injection of, for the treatment of moderate to severe focal spasticity, if: (a) the patient is at least 18 years of age; and (b) the spasticity is associated with a previously diagnosed neurological disorder; and (c) treatment is provided as: (i) second line therapy when standard treatment for the conditions has failed; or (ii) an adjunct to physical therapy; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each limb), including all injections per set; and (e) the treatment is not provided on the same occasion as a service mentioned in item 18365 Sign in to watch this code → Get an email alert when this item changes
	18361	Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of moderate to severe upper limb spasticity due to cerebral palsy if: (a) the patient is at least 2 years of age; and (b) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each upper limb), including all injections per set (Anaes.) Group T11	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18361 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: D Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.07.2011 Gov. Change Flags Fee ≠ Full Description Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of moderate to severe upper limb spasticity due to cerebral palsy if: (a) the patient is at least 2 years of age; and (b) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each upper limb), including all injections per set (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18362	Botulinum Toxin type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of severe primary axillary hyperhidrosis, including all injections on any one day, if: (a) the patient is at least 12 years of age; and (b) the patient has been intolerant of, or has not responded to, topical aluminium chloride hexahydrate; and (c) the patient has not had treatment with botulinum toxin within the immediately preceding 4 months; and (d) if the patient has had treatment with botulinum toxin within the previous 12 months - the patient had treatment on no more than 2 separate occasions (Anaes.) Group T11	Category 3 — Therapeutic Procedures	$295.30	—	≠ CHANGED
Item Number 18362 Schedule Fee $295.30 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.05.2003 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of severe primary axillary hyperhidrosis, including all injections on any one day, if: (a) the patient is at least 12 years of age; and (b) the patient has been intolerant of, or has not responded to, topical aluminium chloride hexahydrate; and (c) the patient has not had treatment with botulinum toxin within the immediately preceding 4 months; and (d) if the patient has had treatment with botulinum toxin within the previous 12 months - the patient had treatment on no more than 2 separate occasions (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18365	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of moderate to severe spasticity of the upper limb following an acute event, if: (a) the patient is at least 18 years of age; and (b) treatment is provided as: (i) second line therapy when standard treatment for the condition has failed; or (ii) an adjunct to physical therapy; and (c) the patient does not have established severe contracture in the limb that is to be treated; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each upper limb), including all injections per set; and (e) for a patient who has received treatment on 2 previous separate occasions - the patient has responded to the treatment Group T11	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18365 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: D Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.04.2015 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of moderate to severe spasticity of the upper limb following an acute event, if: (a) the patient is at least 18 years of age; and (b) treatment is provided as: (i) second line therapy when standard treatment for the condition has failed; or (ii) an adjunct to physical therapy; and (c) the patient does not have established severe contracture in the limb that is to be treated; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each upper limb), including all injections per set; and (e) for a patient who has received treatment on 2 previous separate occasions - the patient has responded to the treatment Sign in to watch this code → Get an email alert when this item changes
	18366	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of strabismus, including all such injections on any one day and associated electromyography (Anaes.) Group T11	Category 3 — Therapeutic Procedures	$187.25	—	≠ CHANGED
Item Number 18366 Schedule Fee $187.25 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.05.2003 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of strabismus, including all such injections on any one day and associated electromyography (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18368	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of spasmodic dysphonia, including all such injections on any one day Group T11	Category 3 — Therapeutic Procedures	$319.60	—	≠ CHANGED
Item Number 18368 Schedule Fee $319.60 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.05.2003 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of spasmodic dysphonia, including all such injections on any one day Sign in to watch this code → Get an email alert when this item changes
	18369	Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of unilateral blepharospasm in a patient who is at least 18 years of age, including all such injections on any one day (Anaes.) Group T11	Category 3 — Therapeutic Procedures	$53.90	—	≠ CHANGED
Item Number 18369 Schedule Fee $53.90 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: D Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.04.2015 Gov. Change Flags Fee ≠ Full Description Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of unilateral blepharospasm in a patient who is at least 18 years of age, including all such injections on any one day (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18370	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of unilateral blepharospasm in a patient who is at least 12 years of age, including all such injections on any one day (Anaes.) Group T11	Category 3 — Therapeutic Procedures	$53.90	—	≠ CHANGED
Item Number 18370 Schedule Fee $53.90 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.05.2003 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of unilateral blepharospasm in a patient who is at least 12 years of age, including all such injections on any one day (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18372	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of bilateral blepharospasm, in a patient who is at least 12 years of age; including all such injections on any one day (Anaes.) Group T11	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18372 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.2006 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of bilateral blepharospasm, in a patient who is at least 12 years of age; including all such injections on any one day (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18374	Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of bilateral blepharospasm in a patient who is at least 18 years of age, including all such injections on any one day (Anaes.) Group T11	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18374 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: D Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.04.2015 Gov. Change Flags Fee ≠ Full Description Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of bilateral blepharospasm in a patient who is at least 18 years of age, including all such injections on any one day (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18375	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesical injection of, with cystoscopy, for the treatment of urinary incontinence, including all such injections on any one day, if: (a) the urinary incontinence is due to neurogenic detrusor overactivity as demonstrated by urodynamic study of a patient with: (i) multiple sclerosis; or (ii) spinal cord injury; or (iii) spina bifida and who is at least 18 years of age; and (b) the patient has urinary incontinence that is inadequately controlled by anti-cholinergic therapy, as manifested by having experienced at least 14 episodes of urinary incontinence per week before commencement of treatment with botulinum toxin type A; and (c) the patient is willing and able to self-catheterise; and (d) the requirements relating to botulinum toxin type A under the Pharmaceutical Benefits Scheme are complied with; and (e) treatment is not provided on the same occasion as a service described in item 104, 105, 110, 116, 119, 11900 or 11919 For each patient - applicable not more than once except if the patient achieves at least a 50% reduction in urinary incontinence episodes from baseline at any time during the period of 6 to 12 weeks after first treatment (Anaes.) Group T11	Category 3 — Therapeutic Procedures	$275.15	—	≠ CHANGED
Item Number 18375 Schedule Fee $275.15 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: D Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.10.2013 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesical injection of, with cystoscopy, for the treatment of urinary incontinence, including all such injections on any one day, if: (a) the urinary incontinence is due to neurogenic detrusor overactivity as demonstrated by urodynamic study of a patient with: (i) multiple sclerosis; or (ii) spinal cord injury; or (iii) spina bifida and who is at least 18 years of age; and (b) the patient has urinary incontinence that is inadequately controlled by anti-cholinergic therapy, as manifested by having experienced at least 14 episodes of urinary incontinence per week before commencement of treatment with botulinum toxin type A; and (c) the patient is willing and able to self-catheterise; and (d) the requirements relating to botulinum toxin type A under the Pharmaceutical Benefits Scheme are complied with; and (e) treatment is not provided on the same occasion as a service described in item 104, 105, 110, 116, 119, 11900 or 11919 For each patient - applicable not more than once except if the patient achieves at least a 50% reduction in urinary incontinence episodes from baseline at any time during the period of 6 to 12 weeks after first treatment (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	18377	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of chronic migraine, including all injections in 1 day, if: (a) the patient is at least 18 years of age; and (b) the patient has experienced an inadequate response, intolerance or contraindication to at least 3 prophylactic migraine medications before commencement of treatment with botulinum toxin, as manifested by an average of 15 or more headache days per month, with at least 8 days of migraine, over a period of at least 6 months, before commencement of treatment with botulinum toxin; and (c) the requirements relating to botulinum toxin type A under the Pharmaceutical Benefits Scheme are complied with For each patient-applicable not more than twice except if the patient achieves and maintains at least a 50% reduction in the number of headache days per month from baseline after 2 treatment cycles (each of 12 weeks duration) Group T11	Category 3 — Therapeutic Procedures	$149.45	—	≠ CHANGED
Item Number 18377 Schedule Fee $149.45 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.03.2014 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of chronic migraine, including all injections in 1 day, if: (a) the patient is at least 18 years of age; and (b) the patient has experienced an inadequate response, intolerance or contraindication to at least 3 prophylactic migraine medications before commencement of treatment with botulinum toxin, as manifested by an average of 15 or more headache days per month, with at least 8 days of migraine, over a period of at least 6 months, before commencement of treatment with botulinum toxin; and (c) the requirements relating to botulinum toxin type A under the Pharmaceutical Benefits Scheme are complied with For each patient-applicable not more than twice except if the patient achieves and maintains at least a 50% reduction in the number of headache days per month from baseline after 2 treatment cycles (each of 12 weeks duration) Sign in to watch this code → Get an email alert when this item changes
	18379	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesical injection of, with cystoscopy, for the treatment of urinary incontinence, including all such injections on any one day, if: (a) the urinary incontinence is due to idiopathic overactive bladder in a patient: and (b) the patient is at least 18 years of age; and (c) the patient has urinary incontinence that is inadequately controlled by at least 2 alternative anti- cholinergic agents, as manifested by having experienced at least 14 episodes of urinary incontinence per week before commencement of treatment with botulinum toxin; and (d) the patient is willing and able to self-catheterise; and (e) treatment is not provided on the same occasion as a service mentioned in item 104, 105, 110, 116, 119, 11900 or 11919 For each patient-applicable not more than once except if the patient achieves at least a 50% reduction in urinary incontinence episodes from baseline at any time during the period of 6 to 12 weeks after first treatment (H) (Anaes.) Group T11	Category 3 — Therapeutic Procedures	$275.15	—	≠ CHANGED
Item Number 18379 Schedule Fee $275.15 Category Category 3 — Therapeutic Procedures Group / Subheading Group T11 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2014 Gov. Change Flags Fee ≠ Full Description Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesical injection of, with cystoscopy, for the treatment of urinary incontinence, including all such injections on any one day, if: (a) the urinary incontinence is due to idiopathic overactive bladder in a patient: and (b) the patient is at least 18 years of age; and (c) the patient has urinary incontinence that is inadequately controlled by at least 2 alternative anti- cholinergic agents, as manifested by having experienced at least 14 episodes of urinary incontinence per week before commencement of treatment with botulinum toxin; and (d) the patient is willing and able to self-catheterise; and (e) treatment is not provided on the same occasion as a service mentioned in item 104, 105, 110, 116, 119, 11900 or 11919 For each patient-applicable not more than once except if the patient achieves at least a 50% reduction in urinary incontinence episodes from baseline at any time during the period of 6 to 12 weeks after first treatment (H) (Anaes.) Sign in to watch this code → Get an email alert when this item changes
	19000	Menopause and Perimenopause Health Assessment Professional attendance on a patient for the assessment and management of menopause or perimenopause by a prescribed medical practitioner lasting at least 20 minutes and including, but not limited to: a) collecting relevant information, including taking a patient history to determine pre-, peri- or post-menopausal status, patient wellbeing and contraindications for management; and b) undertaking a basic physical examination, including recording blood pressure, and review of height and weight; and c) initiating investigations and referrals as clinically indicated, with consideration given to the need for cervical screening, mammography and bone densitometry; and d) discussing management options including non-pharmacological and pharmacological strategies including risks and benefits; e) implementing a management plan which includes patient centred symptoms management; and f) providing the patient with preventative health care advice and information as clinically indicated, including advice on physical activity, smoking cessation, alcohol consumption, nutritional intake and weight management. Group A7	Category 1 — Professional Attendances	$83.60	$83.60	≠ CHANGED
Item Number 19000 Schedule Fee $83.60 Benefits 100%: $83.60 Category Category 1 — Professional Attendances Group / Subheading Group A7 Type Codes Item: D Fee: N Benefit: E Effective Dates Fee from: 01.07.2026 Item from: 01.07.2025 EMSN Cap Max: $500.00 %: 300% Gov. Change Flags Fee ≠ Full Description Menopause and Perimenopause Health Assessment Professional attendance on a patient for the assessment and management of menopause or perimenopause by a prescribed medical practitioner lasting at least 20 minutes and including, but not limited to: a) collecting relevant information, including taking a patient history to determine pre-, peri- or post-menopausal status, patient wellbeing and contraindications for management; and b) undertaking a basic physical examination, including recording blood pressure, and review of height and weight; and c) initiating investigations and referrals as clinically indicated, with consideration given to the need for cervical screening, mammography and bone densitometry; and d) discussing management options including non-pharmacological and pharmacological strategies including risks and benefits; e) implementing a management plan which includes patient centred symptoms management; and f) providing the patient with preventative health care advice and information as clinically indicated, including advice on physical activity, smoking cessation, alcohol consumption, nutritional intake and weight management. Sign in to watch this code → Get an email alert when this item changes
	20100	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin, subcutaneous tissue, muscles, salivary glands or superficial vessels of the head including biopsy, not being a service to which another item in this Subgroup applies (5 basic units) Group T10	Category 3 — Therapeutic Procedures	$118.50	—	≠ CHANGED
Item Number 20100 Schedule Fee $118.50 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin, subcutaneous tissue, muscles, salivary glands or superficial vessels of the head including biopsy, not being a service to which another item in this Subgroup applies (5 basic units) Sign in to watch this code → Get an email alert when this item changes
	20102	Initiation of the management of anaesthesia for plastic repair of cleft lip (H) (6 basic units) Group T10	Category 3 — Therapeutic Procedures	$142.20	—	≠ CHANGED
Item Number 20102 Schedule Fee $142.20 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for plastic repair of cleft lip (H) (6 basic units) Sign in to watch this code → Get an email alert when this item changes
	20104	Initiation of the management of anaesthesia for electroconvulsive therapy (H) (4 basic units) Group T10	Category 3 — Therapeutic Procedures	$94.80	—	≠ CHANGED
Item Number 20104 Schedule Fee $94.80 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for electroconvulsive therapy (H) (4 basic units) Sign in to watch this code → Get an email alert when this item changes
	20120	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on external, middle or inner ear, including biopsy, not being a service to which another item in this Subgroup applies (5 basic units) Group T10	Category 3 — Therapeutic Procedures	$118.50	—	≠ CHANGED
Item Number 20120 Schedule Fee $118.50 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on external, middle or inner ear, including biopsy, not being a service to which another item in this Subgroup applies (5 basic units) Sign in to watch this code → Get an email alert when this item changes
	20124	Initiation of the management of anaesthesia for otoscopy (H) (4 basic units) Group T10	Category 3 — Therapeutic Procedures	$94.80	—	≠ CHANGED
Item Number 20124 Schedule Fee $94.80 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for otoscopy (H) (4 basic units) Sign in to watch this code → Get an email alert when this item changes
	20140	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on eye, not being a service to which another item in this Group applies (5 basic units) Group T10	Category 3 — Therapeutic Procedures	$118.50	—	≠ CHANGED
Item Number 20140 Schedule Fee $118.50 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on eye, not being a service to which another item in this Group applies (5 basic units) Sign in to watch this code → Get an email alert when this item changes
	20142	Initiation of the management of anaesthesia for lens surgery (H) (5 basic units) Group T10	Category 3 — Therapeutic Procedures	$118.50	—	≠ CHANGED
Item Number 20142 Schedule Fee $118.50 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for lens surgery (H) (5 basic units) Sign in to watch this code → Get an email alert when this item changes
	20143	Initiation of the management of anaesthesia for retinal surgery (H) (6 basic units) Group T10	Category 3 — Therapeutic Procedures	$142.20	—	≠ CHANGED
Item Number 20143 Schedule Fee $142.20 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for retinal surgery (H) (6 basic units) Sign in to watch this code → Get an email alert when this item changes
	20144	Initiation of the management of anaesthesia for corneal transplant (H) (7 basic units) Group T10	Category 3 — Therapeutic Procedures	$165.90	—	≠ CHANGED
Item Number 20144 Schedule Fee $165.90 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for corneal transplant (H) (7 basic units) Sign in to watch this code → Get an email alert when this item changes
	20145	Initiation of the management of anaesthesia for vitrectomy (H) (7 basic units) Group T10	Category 3 — Therapeutic Procedures	$165.90	—	≠ CHANGED
Item Number 20145 Schedule Fee $165.90 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for vitrectomy (H) (7 basic units) Sign in to watch this code → Get an email alert when this item changes
	20146	Initiation of the management of anaesthesia for biopsy of conjunctiva (H) (5 basic units) Group T10	Category 3 — Therapeutic Procedures	$118.50	—	≠ CHANGED
Item Number 20146 Schedule Fee $118.50 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for biopsy of conjunctiva (H) (5 basic units) Sign in to watch this code → Get an email alert when this item changes
	20147	Initiation of the management of anaesthesia for squint repair (H) (6 basic units) Group T10	Category 3 — Therapeutic Procedures	$142.20	—	≠ CHANGED
Item Number 20147 Schedule Fee $142.20 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.07.2008 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for squint repair (H) (6 basic units) Sign in to watch this code → Get an email alert when this item changes
	20148	INITIATION OF MANAGEMENT OF ANAESTHESIA for ophthalmoscopy (4 basic units) Group T10	Category 3 — Therapeutic Procedures	$94.80	—	≠ CHANGED
Item Number 20148 Schedule Fee $94.80 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description INITIATION OF MANAGEMENT OF ANAESTHESIA for ophthalmoscopy (4 basic units) Sign in to watch this code → Get an email alert when this item changes
	20160	Initiation of the management of anaesthesia for intranasal procedures on nose or accessory sinuses, other than a service to which another item in this Subgroup applies (H) (6 basic units) Group T10	Category 3 — Therapeutic Procedures	$142.20	—	≠ CHANGED
Item Number 20160 Schedule Fee $142.20 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for intranasal procedures on nose or accessory sinuses, other than a service to which another item in this Subgroup applies (H) (6 basic units) Sign in to watch this code → Get an email alert when this item changes
	20162	Initiation of the management of anaesthesia for intranasal surgery for malignancy or for intranasal ablation (H) (7 basic units) Group T10	Category 3 — Therapeutic Procedures	$165.90	—	≠ CHANGED
Item Number 20162 Schedule Fee $165.90 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for intranasal surgery for malignancy or for intranasal ablation (H) (7 basic units) Sign in to watch this code → Get an email alert when this item changes
	20164	Initiation of the management of anaesthesia for biopsy of soft tissue of the nose and accessory sinuses (H) (4 basic units) Group T10	Category 3 — Therapeutic Procedures	$94.80	—	≠ CHANGED
Item Number 20164 Schedule Fee $94.80 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for biopsy of soft tissue of the nose and accessory sinuses (H) (4 basic units) Sign in to watch this code → Get an email alert when this item changes
	20170	INITIATION OF MANAGEMENT OF ANAESTHESIA for intraoral procedures, including biopsy, not being a service to which another item in this Subgroup applies (6 basic units) Group T10	Category 3 — Therapeutic Procedures	$142.20	—	≠ CHANGED
Item Number 20170 Schedule Fee $142.20 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: C Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description INITIATION OF MANAGEMENT OF ANAESTHESIA for intraoral procedures, including biopsy, not being a service to which another item in this Subgroup applies (6 basic units) Sign in to watch this code → Get an email alert when this item changes
	20172	Initiation of the management of anaesthesia for repair of cleft palate (H) (7 basic units) Group T10	Category 3 — Therapeutic Procedures	$165.90	—	≠ CHANGED
Item Number 20172 Schedule Fee $165.90 Category Category 3 — Therapeutic Procedures Group / Subheading Group T10 Type Codes Item: S Fee: N Benefit: A Effective Dates Fee from: 01.07.2026 Item from: 01.11.2001 Gov. Change Flags Fee ≠ Full Description Initiation of the management of anaesthesia for repair of cleft palate (H) (7 basic units) Sign in to watch this code → Get an email alert when this item changes

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

PARAVERTEBRAL NERVES, injection of an anaesthetic agent, (multiple levels)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Sciatic nerve, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Sphenopalatine ganglion, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Carotid sinus, injection of an anaesthetic agent, as an independent percutaneous procedure (H)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Cervical or thoracic sympathetic chain, injection of an anaesthetic agent (H) (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Lumbar or pelvic sympathetic chain, injection of an anaesthetic agent (H) (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Coeliac plexus or splanchnic nerves, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach (H) (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Cranial nerve other than trigeminal, destruction by a neurolytic agent under image guidance, other than a service associated with the injection of botulinum toxin (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Nerve branch, destruction by a neurolytic agent under image guidance, other than a service to which another item in this Group applies or a service associated with the injection of botulinum toxin except a service to which item 18354 applies (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Coeliac plexus or splanchnic nerves, destruction by a neurolytic agent under image guidance (H) (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Lumbar or pelvic sympathetic chain, destruction by a neurolytic agent under image guidance (H) (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Assistance at the administration of an epidural blood patch (a service to which item 18233 applies) by another medical practitioner

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

CERVICAL OR THORACIC SYMPATHETIC CHAIN, destruction by a neurolytic agent (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of hemifacial spasm in a patient who is at least 12 years of age, including all such injections on any one day

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport), injection of, for the treatment of hemifacial spasm in a patient who is at least 18 years of age, including all such injections on any one day

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of dynamic equinus foot deformity (including equinovarus and equinovalgus) due to spasticity from cerebral palsy, if: (a) the patient is at least 2 years of age; and (b) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each lower limb), including all injections per set (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

IncobotulinumtoxinA (Xeomin), injection of, for the treatment of chronic sialorrhea in a patient who is at least 2 years of age, if the condition is due to a neurological or neurodevelopmental disorder, including all such injections on any one day (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), or Clostridium Botulinum Type A Toxin Haemagglutinin Complex (Dysport), injection of, for the treatment of moderate to severe focal spasticity, if: (a) the patient is at least 18 years of age; and (b) the spasticity is associated with a previously diagnosed neurological disorder; and (c) treatment is provided as: (i) second line therapy when standard treatment for the conditions has failed; or (ii) an adjunct to physical therapy; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each limb), including all injections per set; and (e) the treatment is not provided on the same occasion as a service mentioned in item 18365

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of moderate to severe upper limb spasticity due to cerebral palsy if: (a) the patient is at least 2 years of age; and (b) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each upper limb), including all injections per set (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Botulinum Toxin type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of severe primary axillary hyperhidrosis, including all injections on any one day, if: (a) the patient is at least 12 years of age; and (b) the patient has been intolerant of, or has not responded to, topical aluminium chloride hexahydrate; and (c) the patient has not had treatment with botulinum toxin within the immediately preceding 4 months; and (d) if the patient has had treatment with botulinum toxin within the previous 12 months - the patient had treatment on no more than 2 separate occasions (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of moderate to severe spasticity of the upper limb following an acute event, if: (a) the patient is at least 18 years of age; and (b) treatment is provided as: (i) second line therapy when standard treatment for the condition has failed; or (ii) an adjunct to physical therapy; and (c) the patient does not have established severe contracture in the limb that is to be treated; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each upper limb), including all injections per set; and (e) for a patient who has received treatment on 2 previous separate occasions - the patient has responded to the treatment

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of strabismus, including all such injections on any one day and associated electromyography (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of spasmodic dysphonia, including all such injections on any one day

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of unilateral blepharospasm in a patient who is at least 18 years of age, including all such injections on any one day (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of unilateral blepharospasm in a patient who is at least 12 years of age, including all such injections on any one day (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of bilateral blepharospasm, in a patient who is at least 12 years of age; including all such injections on any one day (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of bilateral blepharospasm in a patient who is at least 18 years of age, including all such injections on any one day (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesical injection of, with cystoscopy, for the treatment of urinary incontinence, including all such injections on any one day, if: (a) the urinary incontinence is due to neurogenic detrusor overactivity as demonstrated by urodynamic study of a patient with: (i) multiple sclerosis; or (ii) spinal cord injury; or (iii) spina bifida and who is at least 18 years of age; and (b) the patient has urinary incontinence that is inadequately controlled by anti-cholinergic therapy, as manifested by having experienced at least 14 episodes of urinary incontinence per week before commencement of treatment with botulinum toxin type A; and (c) the patient is willing and able to self-catheterise; and (d) the requirements relating to botulinum toxin type A under the Pharmaceutical Benefits Scheme are complied with; and (e) treatment is not provided on the same occasion as a service described in item 104, 105, 110, 116, 119, 11900 or 11919 For each patient - applicable not more than once except if the patient achieves at least a 50% reduction in urinary incontinence episodes from baseline at any time during the period of 6 to 12 weeks after first treatment (Anaes.)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of chronic migraine, including all injections in 1 day, if: (a) the patient is at least 18 years of age; and (b) the patient has experienced an inadequate response, intolerance or contraindication to at least 3 prophylactic migraine medications before commencement of treatment with botulinum toxin, as manifested by an average of 15 or more headache days per month, with at least 8 days of migraine, over a period of at least 6 months, before commencement of treatment with botulinum toxin; and (c) the requirements relating to botulinum toxin type A under the Pharmaceutical Benefits Scheme are complied with For each patient-applicable not more than twice except if the patient achieves and maintains at least a 50% reduction in the number of headache days per month from baseline after 2 treatment cycles (each of 12 weeks duration)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesical injection of, with cystoscopy, for the treatment of urinary incontinence, including all such injections on any one day, if: (a) the urinary incontinence is due to idiopathic overactive bladder in a patient: and (b) the patient is at least 18 years of age; and (c) the patient has urinary incontinence that is inadequately controlled by at least 2 alternative anti- cholinergic agents, as manifested by having experienced at least 14 episodes of urinary incontinence per week before commencement of treatment with botulinum toxin; and (d) the patient is willing and able to self-catheterise; and (e) treatment is not provided on the same occasion as a service mentioned in item 104, 105, 110, 116, 119, 11900 or 11919 For each patient-applicable not more than once except if the patient achieves at least a 50% reduction in urinary incontinence episodes from baseline at any time during the period of 6 to 12 weeks after first treatment (H) (Anaes.)

100% Benefit

$83.60

Fee From

01.07.2026

Category

Category 1 — Professional Attendances

Description

Menopause and Perimenopause Health Assessment Professional attendance on a patient for the assessment and management of menopause or perimenopause by a prescribed medical practitioner lasting at least 20 minutes and including, but not limited to: a) collecting relevant information, including taking a patient history to determine pre-, peri- or post-menopausal status, patient wellbeing and contraindications for management; and b) undertaking a basic physical examination, including recording blood pressure, and review of height and weight; and c) initiating investigations and referrals as clinically indicated, with consideration given to the need for cervical screening, mammography and bone densitometry; and d) discussing management options including non-pharmacological and pharmacological strategies including risks and benefits; e) implementing a management plan which includes patient centred symptoms management; and f) providing the patient with preventative health care advice and information as clinically indicated, including advice on physical activity, smoking cessation, alcohol consumption, nutritional intake and weight management.

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin, subcutaneous tissue, muscles, salivary glands or superficial vessels of the head including biopsy, not being a service to which another item in this Subgroup applies (5 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for plastic repair of cleft lip (H) (6 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for electroconvulsive therapy (H) (4 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on external, middle or inner ear, including biopsy, not being a service to which another item in this Subgroup applies (5 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for otoscopy (H) (4 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on eye, not being a service to which another item in this Group applies (5 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for lens surgery (H) (5 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for retinal surgery (H) (6 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for corneal transplant (H) (7 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for vitrectomy (H) (7 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for biopsy of conjunctiva (H) (5 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for squint repair (H) (6 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

INITIATION OF MANAGEMENT OF ANAESTHESIA for ophthalmoscopy (4 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for intranasal procedures on nose or accessory sinuses, other than a service to which another item in this Subgroup applies (H) (6 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for intranasal surgery for malignancy or for intranasal ablation (H) (7 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for biopsy of soft tissue of the nose and accessory sinuses (H) (4 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

INITIATION OF MANAGEMENT OF ANAESTHESIA for intraoral procedures, including biopsy, not being a service to which another item in this Subgroup applies (6 basic units)

Fee From

01.07.2026

Category

Category 3 — Therapeutic Procedures

Description

Initiation of the management of anaesthesia for repair of cleft palate (H) (7 basic units)

← Prev 16 17 18 19 20 Next →

50 items per page · tap/click any row to expand

MBS Item Tracker